// App-Quantinova.ai

7563 : A comparative study of blood-based KRAS mutation analysis in circulating tumor cells versus circulating plasma DNA to predict primary tumor mutations in lung cancer.

Researchers

Presenter

  • Eric Kian Saik Lim

Principal Investigators

  • Maxim B Freidin

  • Sanjay Popat

  • David Gonzalez de Castro

  • Alexandra Rice

  • Vladimir Anikin

  • Angeles Montero Fernandez

  • Andrew G Nicholson

  • Dasha V Freydina

  • Dimple Chudasama

  • Maria Leung

Medical Centers

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Royal Brompton Hospital, London, United KingdomRoyal Brompton and Harefield NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

Biomarkers

  • Circulating tumor cells

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved